Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Land & Improvements (2016 - 2019)

Myriad Genetics (MYGN) has disclosed Land & Improvements for 5 consecutive years, with $2.2 million as the latest value for Q3 2019.

  • Quarterly Land & Improvements fell 8.33% to $2.2 million in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Sep 2019, down 8.33% year-over-year, with the annual reading at $2.3 million for FY2019, 4.17% down from the prior year.
  • Land & Improvements for Q3 2019 was $2.2 million at Myriad Genetics, down from $2.3 million in the prior quarter.
  • The five-year high for Land & Improvements was $2.5 million in Q4 2017, with the low at $2.2 million in Q4 2016.
  • Average Land & Improvements over 5 years is $2.3 million, with a median of $2.3 million recorded in 2015.
  • The sharpest move saw Land & Improvements increased 13.64% in 2017, then decreased 8.33% in 2019.
  • Over 5 years, Land & Improvements stood at $2.3 million in 2015, then dropped by 4.35% to $2.2 million in 2016, then rose by 13.64% to $2.5 million in 2017, then dropped by 4.0% to $2.4 million in 2018, then dropped by 8.33% to $2.2 million in 2019.
  • According to Business Quant data, Land & Improvements over the past three periods came in at $2.2 million, $2.3 million, and $2.3 million for Q3 2019, Q2 2019, and Q1 2019 respectively.